| Literature DB >> 33815247 |
Radhika Sood1, Jean-Marie Annoni1,2, Andrea M Humm1, Ettore Accolla1, Olivier Bill3, Guillermo Toledo Sotomayor3, Julien Niederhauser3, Friedrich Medlin1.
Abstract
Background and Aims: Timely administration of recombinant tissue plasminogen activator (r-tPA) improves clinical outcomes in acute ischemic stroke patients. This study aims to explore the influence of the systematic presence on site of a neurologist compared with telestroke management on door-to-needle time in acute ischemic stroke outside of working hours (OWH).Entities:
Keywords: acute ischemic stroke; door-to-needle time; neurologist; teleradiology for acute stroke management; thrombolysis
Year: 2021 PMID: 33815247 PMCID: PMC8017204 DOI: 10.3389/fneur.2021.616620
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Site-specific demographics and clinical characteristics; demographics and clinical characteristics as per admission time.
| Age, mean (SD) (IQR), years | 73.1 (14.1) (22) | 71.9 (14.8) (18) | 0.523 | 73.9 (15) (19) | 70.7 (13.9) (21) | 0.076 | 72.3 (14.5) (19.7) |
| Male sex (%) | 54.5 | 54.8 | 0.960 | 50.8 | 58.6 | 0.207 | 54.7 |
| Arterial hypertensio | 66.3 | 66.2 | 0.519 | 68.5 | 64.0 | 0.305 | 66.5 |
| Diabetes (%) | 15.8 | 16.6 | 0.263 | 18.5 | 14.0 | 0.394 | 16.3 |
| Smoker (%) | 13.9 | 17.2 | 14.6 | 17.2 | 0.274 | 15.9 | |
| Atrial fibrillation (%) | 24.8 | 24.1 | 0.194 | 25.4 | 23.4 | 0.377 | 24.4 |
| Anticoagulation (%) | 6.9 | 0.6 | 3.07 | 3.13 | 0.982 | 3.1 | |
| Pre-mRs, median (SD) | 0 (1.14) | 0 (1.05) | 0.662 | 0 (1.15) | 0 (1.02) | 0.202 | 0 (1.09) |
| NIHSS, median (SD), (IQR) | 6 (6.88) (5) | 8 (6.98) (11) | 6.50 (6.88) (9) | 8 (7.20) (10) | 0.550 | 7 (7.04) (9.00) | |
| Transfer to adjacent stroke center for potential endovascular treatment following thrombolysis (%) | 14.9 | 26.1 | 20.0 | 23.4 | 0.503 | 21.7 | |
GHOL, Groupement Hospitalier de l'Ouest Lémanique; HFR, Hôpital de Fribourg; IQR, interquartile range; mRs, Modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
p: Determined by use of the independent samples T-test for age, NIHSS on admission, and pre-mRs. The χ.
Statistically Significant values are indicated in bold (p ≤ 0.05).
Inter-site-specific demographics and clinical characteristics according to admission time.
| Age, mean (SD) (IQR), years | 74.1 (13.6) (52) | 72.1 (14.6) (64) | 0.483 | 73.8 (15.9) (74) | 69.8 (13.4) (69) | 0.088 |
| Male sex (%) | 54 | 55 | 0.557 | 48.8 | 61 | 0.123 |
| Arterial hypertension (%) | 62 | 70.6 | 0.364 | 72.5 | 59.7 | 0.076 |
| Diabetes (%) | 14 | 17.6 | 0.618 | 21.3 | 11.7 | 0.323 |
| Smoker (%) | 14 | 13.7 | 0.968 | 15 | 19.5 | 0.119 |
| Atrial fibrillation (%) | 26 | 23.5 | 0.775 | 25 | 23.4 | 0.525 |
| Anticoagulatio | 6 | 9.8 | 0.717 | 1.25 | 0 | 0.327 |
| Pre-mRs, median (SD) | 0 (1.22) | 0 (1.05) | 0.267 | 0 (1.11) | 0 (0.997) | 0.468 |
| NIHSS, median (SD), (IQR) | 7 (6.66) (26) | 5 (7.13) (36) | 0.558 | 6 (7.02) (29) | 9 (6.92) (27) | 0.199 |
| Transfer to adjacent stroke center for potential endovascular treatment following thrombolysis (%) | 16 | 13.7 | 0.749 | 22.5 | 29.9 | 0.295 |
GHOL, Groupement Hospitalier de l'Ouest Lémanique; HFR, Hôpital de Fribourg; IQR, interquartile range; mRs, Modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
p: Determined by use of the independent samples T-test for age, NIHSS on admission, and pre-mRs. The χ.
Door-to-needle time according to center (GHOL and HFR) and admission time (working hours vs. outside of working hours).
| GHOL ( | 22.0 ± 4.85 (17.1, 26.9) (17.5) | 30.0 ± 7.82 (22.2, 37.8) (28.5) | ||
| HFR ( | 42.0 ± 4.29 (37.7, 46.3) (19.6) | 52.0 ± 4.53 (47.5, 56.5) (20.3) | ||
GHOL, Groupement Hospitalier de l'Ouest Lémanique; HFR, Hôpital de Fribourg; IQR, interquartile range; mRs, Modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.
p: Determined by use of the independent samples T-test, with representation of E.
Statistically Significant values are indicated in bold (p ≤ 0.05).
Figure 1Pre-mRs compared with post-mRs evaluated 90 days following acute ischemic stroke according to admission time. mRs, Modified Rankin Scale.